A Single Dose of Recombinant Activated Factor VII (NovoSeven®) Did Not Impair the Function of the Coronary Artery Bypass Grafts – Successful Treatment of Critical Bleeding after Cardiac Surgery in Two Cases

Publisher: Karger

E-ISSN: 1660-3818|34|3|204-207

ISSN: 1660-3796

Source: Transfusion Medicine and Hemotherapy, Vol.34, Iss.3, 2007-05, pp. : 204-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content